Canada Markets closed

Intersect ENT, Inc. (XENT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
28.240.00 (0.00%)
At close: 04:00PM EDT
Sign in to post a message.
  • A
    Anonymous
    Gapping up here on rumor that Medtronic makes take over offer, stock gapping up over its 200-day moving average at $17.91. watching for this to hold as support on any pullback and watching for a push to test $25.00. http://daytrading.group/xwyu5
    True Trading Group Home Page - True Trading Group
    daytrading.group
  • D
    Dave
    1. Northland Securities analysts commented, "We were not allowed to ask questions on the call, but to any rational observer, it is hard to reconcile commentary about the rosy outlook and the CEO’s departure. The abrupt CEO change at a pivotal time in the company’s history telegraphs implicit weakness in the outlook. Downgrading to UP / $20 PT. Key Points All eyes are on level of J-code reimbursement for SINUVA beginning Jan 2020. Company mentioned billing to the tune of 135x that of a 10mcg MF injectable drug. Recent decisions by Anthem and Aetna (drug formulation & medical policy, respectively) continues. The use of an unassigned J-code continues, and roughly 185 physicians engaged in buy & bill" by end of in Q4-18. Average buy in these accounts = 1 unit. ASP = $1,000 / implant. Pre-auth times for SINUVA have come down from ~1month around Q3-18 to a current run rate of 2-weeks or so." (5/7/2019)
  • H
    Health Master
    (XENT) Intersect ENT Inc.

    Summary Highlights:

    - Positive 10 day & 50 day Moving Average
    - Current Assets to Liabilities ratio attractive
    - Enterprise Value is undervalued compared to peer group
    - Moving Average Convergence Divergence crossing higher
    - 5 Day Rounding Bottom chart formation bullish (Cup & Handle)

    Ears, Nose, Throat Devices Market to reach $26BB, bio-absorbable devices such as Propel & Sinuva fastest growing segment.

    Ear-Nose-Throat Devices Market, ENT Devices Market Size, Share, Trends | Forecast 2026
    The global ear-nose-throat devices market is expected to grow at a significant CAGR around 8% throughout the forecast period and reach around US$ 26 billion by 2026.

    https://www.acumenresearchandconsulting.com/ear-nose-throat-ent-devices-market

    (XENT) capturing 5% of market realize $1.3BB in revenues/ 32MM Shares = 40$ per share in Revenue, at comp. 10X Sales= $200 per share
    The global ear-nose-throat devices market is expected to grow at a significant CAGR around 8% throughout the forecast period and reach around US$ 26 billion by 2026.
    The global ear-nose-throat devices market is expected to grow at a significant CAGR around 8% throughout the forecast period and reach around US$ 26 billion by 2026.
    www.acumenresearchandconsulting.com
  • F
    Fly
    Medtronic buying and no discussion here. Weird?
  • A
    Anonymous
    Warning orchestrated pumpoing ongoing just raise more money at better price ..DILUTION IMMINENT = BACK TO LOW $20 OR LOWER QUICKLY ..Pure Ponzi scheme Scam
  • F
    Fethi
    Brokerages forecast that Bellus Health Inc. (NYSE:BLU) will report ($0.19) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Bellus Health’s earnings, with the highest E
    Brokerages forecast that Bellus Health Inc. (NYSE:BLU) will report ($0.19) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Bellus Health’s earnings, with the highest E
    www.dispatchtribunal.com
  • P
    Peter
    Does anyone have any information on the possible Medtronic interest in XENT?
  • R
    Ram
    Looks like upside tomorrow
  • B
    Biolover
    UNPROFITABLE $1 BILLION BUBBLE TRASH WITH A LAUGHABLE BOOK VALUE OF JUST $3.88 = STRONG SELLLLLLLLL THIS MONSTER BUBBLE SCAM ..Looks like brutal stock promotion is ongoing to attract new bagholders so the criminal banksters and management can unload their brutally overpriced trash to them . Fair Value should be closer to book value so around $6-7 AT MAX .GL anyway
  • b
    blue
    GETREADYTO TAKEMONEY OFFTHETABLE AS SOON AS THEBELLOPENINGTHIS WIL CRASH CRASHBACK DOWN BELOW $7 NOTHING HAS CHANGED GET READY TO DUMP DUMP YOUR SHARES ATTHEOPENINGBELL
  • Y
    Yahoo Finance Insights
    XENT is up 6.41% to 27.83
  • L
    Laser
    1.3 billion mkt cap. Even if they execute can this stock double or triple?
  • L
    Laser
    $31 a share
  • J
    John
    $500M valuation for a company that has never been profitable??
  • Y
    Yahoo Finance Insights
    XENT is down -16.69% to 26.95
  • Y
    Yahoo Finance Insights
    XENT is down -5.14% to 33.25
  • T
    Timothy
    A close below 25 will send XENT down to the low 20's
  • Y
    Yahoo Finance Insights
    Intersect ENT is up 5.35% to 19.48
  • s
    soflagrtwht
    someone knew things were off track... some analyst upgraded it about 3 months ago, clearly he didn't, or was setting us all up.
  • S
    Stock
    Sounds like Fraud XENT Alert: Johnson Fistel Investigates Intersect ENT, Inc.; Should Management be Held Accountable for Investors Losses? https://finance.yahoo.com/news/xent-alert-johnson-fistel-investigates-135900033.html